Niagen Bioscience, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $54.1M
Liabilities Breakdown FY2022
Total Liabilities: $25.4M
Asset Breakdown
Total Assets: $54.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $20.3M | 37.6% |
| Accounts Receivable | $8.5M | 15.7% |
| Inventory | $14.7M | 27.2% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $671.0K | 1.2% |
| Other Assets | $9.9M | 18.4% |
Liabilities Breakdown
Total Liabilities: $25.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.7M | 38.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $15.7M | 61.9% |